Healthy Vaccinee Bias and MenB-FHbp Vaccine Effectiveness Against Gonorrhea

被引:10
作者
Abara, Winston E. [1 ,5 ]
Bernstein, Kyle T. [1 ]
Lewis, Felicia M. T. [1 ]
Pathela, Preeti [3 ]
Islam, Aras [2 ]
Eberhart, Michael [2 ]
Cheng, Iris [4 ]
Ternier, Alexandra [4 ]
Sanderson Slutsker, Jennifer [3 ]
Madera, Robbie [2 ]
Kirkcaldy, Robert [1 ]
机构
[1] Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA 30333 USA
[2] Philadelphia Dept Publ Hlth, Philadelphia, PA USA
[3] New York City Dept Hlth & Mental Hyg, Bur STI, New York, NY USA
[4] New York City Dept Hlth & Mental Hyg, Bur Immunizat, New York, NY USA
[5] Ctr Dis Control & Prevent, 1600 Clifton Rd, Atlanta, GA 30333 USA
关键词
NEISSERIA-GONORRHOEAE;
D O I
10.1097/OLQ.0000000000001793
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Observational studies demonstrated 30% to 40% effectiveness of outer-membrane vesicle (OMV) meningococcal serogroup B vaccines against gonorrhea. To explore whether healthy vaccinee bias influenced such findings, we examined the effectiveness of MenB-FHbp, a non-OMV vaccine that is not protective against gonorrhea. MenB-FHbp was ineffective against gonorrhea. Healthy vaccinee bias likely did not confound earlier studies of OMV vaccines.
引用
收藏
页码:E8 / E10
页数:3
相关论文
共 23 条
[1]   Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational study [J].
Abara, Winston E. ;
Bernstein, Kyle T. ;
Lewis, Felicia M. T. ;
Schillinger, Julia A. ;
Feemster, Kristen ;
Pathela, Preeti ;
Hariri, Susan ;
Islam, Aras ;
Eberhart, Michael ;
Cheng, Iris ;
Ternier, Alexandra ;
Slutsker, Jennifer Sanderson ;
Mbaeyi, Sarah ;
Madera, Robbie ;
Kirkcaldy, Robert D. .
LANCET INFECTIOUS DISEASES, 2022, 22 (07) :1021-1029
[2]   Planning for a Gonococcal Vaccine: A Narrative Review of Vaccine Development and Public Health Implications [J].
Abara, Winston E. ;
Jerse, Ann E. ;
Hariri, Susan ;
Kirkcaldy, Robert D. .
SEXUALLY TRANSMITTED DISEASES, 2021, 48 (07) :453-457
[3]   A phase 3 study to assess the immunogenicity, safety, and tolerability of MenB-FHbp administered as a 2-dose schedule in adolescents and young adults [J].
Drazan, Daniel ;
Czajka, Hanna ;
Maguire, Jason D. ;
Pregaldien, Jean-Louis ;
Maansson, Roger ;
O'Neill, Robert ;
Anderson, Annaliesa S. ;
Balmer, Paul ;
Beeslaar, Johannes ;
Perez, John L. .
VACCINE, 2022, 40 (02) :351-358
[4]  
Food and Drug Administration, 2018, TRUM
[5]  
Food and Drug Administration, BEXS 2020
[6]   Distinct Binding and Immunogenic Properties of the Gonococcal Homologue of Meningococcal Factor H Binding Protein [J].
Jongerius, Ilse ;
Lavender, Hayley ;
Tan, Lionel ;
Ruivo, Nicola ;
Exley, Rachel M. ;
Caesar, Joseph J. E. ;
Lea, Susan M. ;
Johnson, Steven ;
Tang, Christoph M. .
PLOS PATHOGENS, 2013, 9 (08)
[7]   Trends in antimicrobial resistance in Neisseria gonorrhoeae in the USA: the Gonococcal Isolate Surveillance Project (GISP), January 2006-June 2012 [J].
Kirkcaldy, Robert D. ;
Kidd, Sarah ;
Weinstock, Hillard S. ;
Papp, John R. ;
Bolan, Gail A. .
SEXUALLY TRANSMITTED INFECTIONS, 2013, 89 (04) :5-10
[8]   The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae [J].
Leduc, Isabelle ;
Connolly, Kristie L. ;
Begum, Afrin ;
Underwood, Knashka ;
Darnell, Stephen ;
Shafer, William M. ;
Balthazar, Jacqueline T. ;
Macintyre, Andrew N. ;
Sempowski, Gregory D. ;
Duncan, Joseph A. ;
Little, Marguerite B. ;
Rahman, Nazia ;
Garges, Eric C. ;
Jerse, Ann E. .
PLOS PATHOGENS, 2020, 16 (12)
[9]  
Longtin J., 2017, Open Forum Infectious Diseases, V4, pS734, DOI DOI 10.1093/OFID/OFX180.002
[10]   Pitfalls of the healthy vaccinee effect [J].
Mahmud, Salaheddin M. ;
Righolt, Christiaan H. .
LANCET, 2018, 391 (10116) :123-123